Clinical and histopathological predictors of rapid kidney function decline in patients with biopsy-proven diabetic kidney disease

According to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines, rapid kidney function decline in DKD is defined as an estimated glomerular filtration rate (eGFR) slope ≤-5 mL∙min -1∙1.73 m -2∙year -1. [...]181 T2D patients with kidney biopsy-proven DKD were included in this study. Clin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medical journal 2023-05, Vol.136 (10), p.1243-1245
Hauptverfasser: Zhao, Yiyang, Chang, Dongyuan, Wu, Liang, Yu, Xiaojuan, Wang, Suxia, Zhao, Minghui, Chen, Min
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:According to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines, rapid kidney function decline in DKD is defined as an estimated glomerular filtration rate (eGFR) slope ≤-5 mL∙min -1∙1.73 m -2∙year -1. [...]181 T2D patients with kidney biopsy-proven DKD were included in this study. Clinical data included sex, age, body mass index (BMI), diabetic retinopathy (DR), duration of diabetes, systolic blood pressure (SBP), diastolic blood pressure (DBP), duration of hypertension, proteinuria per 24 h, urinary albumin-to-creatinine ratio (uACR), urinary N-acetylglutamate synthase (NAG), baseline eGFR, serum creatinine (Scr), hemoglobin A1c (HbA1c), platelet count, hemoglobin (Hb), white blood cell (WBC), serum albumin, serum uric acid, triglyceride (TG), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, serum C3, serum C4, and the use of renin–angiotensin–aldosterone system (RAAS) inhibitors and lipid-lowering medications. According to the KDIGO guidelines, non-rapid decliners were defined as eGFR decline slope >-5 mL∙min -1∙1.73 m -2∙year -1 and rapid decliners were defined as eGFR decline slope ≤-5 mL∙min -1∙1.73 m -2∙year -1.
ISSN:0366-6999
2542-5641
DOI:10.1097/CM9.0000000000002673